X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (63614) 63614
Book Review (8907) 8907
Publication (3418) 3418
Newsletter (1013) 1013
Book Chapter (209) 209
Book / eBook (135) 135
Conference Proceeding (87) 87
Dissertation (74) 74
Magazine Article (63) 63
Newspaper Article (47) 47
Data Set (6) 6
Reference (5) 5
Trade Publication Article (5) 5
Web Resource (2) 2
Journal / eJournal (1) 1
Paper (1) 1
Presentation (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (54157) 54157
humans (52362) 52362
female (37448) 37448
male (33080) 33080
middle aged (32760) 32760
aged (29016) 29016
oncology (26104) 26104
cancer (23432) 23432
adult (23026) 23026
prognosis (19491) 19491
carcinoma, squamous cell - mortality (13243) 13243
surgery (13121) 13121
aged, 80 and over (12722) 12722
neoplasm staging (12674) 12674
carcinoma (12475) 12475
squamous cell carcinoma (11906) 11906
carcinoma, squamous cell - pathology (11640) 11640
retrospective studies (10661) 10661
squamous-cell carcinoma (10259) 10259
survival rate (9919) 9919
survival (9694) 9694
metastasis (9631) 9631
chemotherapy (9581) 9581
analysis (8786) 8786
care and treatment (8713) 8713
research (8618) 8618
tumors (8477) 8477
treatment outcome (8052) 8052
expression (7349) 7349
carcinoma, squamous cell - surgery (7207) 7207
risk factors (6941) 6941
radiotherapy (6914) 6914
survival analysis (6793) 6793
abridged index medicus (6781) 6781
follow-up studies (6745) 6745
health aspects (6726) 6726
immunohistochemistry (6267) 6267
lung neoplasms - pathology (6260) 6260
lung cancer (6193) 6193
lung neoplasms - mortality (6052) 6052
disease-free survival (5265) 5265
mortality (5247) 5247
medical prognosis (5210) 5210
esophageal cancer (5187) 5187
medicine & public health (5162) 5162
gene expression (5086) 5086
lymphatic metastasis (5059) 5059
development and progression (4964) 4964
genetic aspects (4801) 4801
pathology (4777) 4777
adenocarcinoma (4697) 4697
combined modality therapy (4650) 4650
apoptosis (4531) 4531
animals (4521) 4521
carcinoma, squamous cell - therapy (4405) 4405
kaplan-meier estimate (4403) 4403
proteins (4403) 4403
diagnosis (4363) 4363
adenocarcinoma - mortality (4319) 4319
cell line, tumor (4303) 4303
head (4298) 4298
patients (4249) 4249
carcinoma, non-small-cell lung - pathology (4191) 4191
carcinoma, non-small-cell lung - mortality (4152) 4152
otorhinolaryngology (4112) 4112
carcinoma, squamous cell - radiotherapy (4008) 4008
adenocarcinoma - pathology (3836) 3836
breast-cancer (3833) 3833
esophageal neoplasms - pathology (3732) 3732
antineoplastic combined chemotherapy protocols - therapeutic use (3714) 3714
cancer therapies (3696) 3696
lung cancer, non-small cell (3658) 3658
esophageal neoplasms - mortality (3610) 3610
respiratory system (3605) 3605
time factors (3554) 3554
studies (3539) 3539
gene expression regulation, neoplastic (3531) 3531
multivariate analysis (3516) 3516
hematology, oncology and palliative medicine (3349) 3349
proportional hazards models (3329) 3329
therapy (3283) 3283
risk (3212) 3212
carcinoma, squamous cell - genetics (3173) 3173
medicine (3129) 3129
oncology, experimental (3119) 3119
neoplasm invasiveness (3036) 3036
biomarkers (2955) 2955
research article (2941) 2941
carcinoma, squamous cell - drug therapy (2940) 2940
head and neck cancer (2926) 2926
radiation-therapy (2925) 2925
lung neoplasms - drug therapy (2880) 2880
medical research (2877) 2877
cervical cancer (2853) 2853
cell biology (2849) 2849
esophageal neoplasms - surgery (2837) 2837
head and neck neoplasms - mortality (2835) 2835
patient outcomes (2826) 2826
metastases (2817) 2817
medicine, research & experimental (2797) 2797
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (100) 100
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Gerstein Science - Circulation Desk (3) 3
Online Resources - Online (3) 3
St. Michael's Hospital - Stacks (3) 3
UTL at Downsview - May be requested (3) 3
Gerstein Science - Reference (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Markham Stouffville Hospital - Stacks (2) 2
St Josephs Health Centre - Stacks (2) 2
Credit Valley Hospital - Special Collections (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Markham Stouffville Hospital - Storage (1) 1
Mt Sinai Hospital - Pathology (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
Trillium Health Centre - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (62469) 62469
German (669) 669
Japanese (432) 432
French (374) 374
Chinese (359) 359
Russian (212) 212
Spanish (174) 174
Italian (125) 125
Polish (93) 93
Portuguese (31) 31
Turkish (27) 27
Hungarian (21) 21
Korean (15) 15
Dutch (12) 12
Hebrew (12) 12
Czech (10) 10
Danish (8) 8
Lithuanian (8) 8
Swedish (8) 8
Romanian (7) 7
Bulgarian (6) 6
Norwegian (6) 6
Serbian (6) 6
Croatian (5) 5
Ukrainian (5) 5
Finnish (4) 4
Persian (4) 4
Icelandic (2) 2
Arabic (1) 1
Latvian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 2, pp. 123 - 135
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2005, Volume 23, Issue 4, pp. 759 - 765
Purpose To identify nonmelanoma skin cancer patients with squamous cell carcinoma (SCC) who are at greatest risk of disease-specific mortality. Patients and... 
RATES | LIP | ONCOLOGY | EPIDEMIC | CARCINOMA | Skin Neoplasms - pathology | Prospective Studies | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Risk Factors | Neoplasm Recurrence, Local | Male | Carcinoma, Squamous Cell - mortality | Skin Neoplasms - mortality | Aged, 80 and over | Adult | Female | Aged | Longitudinal Studies | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1236 - 1244
Summary Background With use of EGFR tyrosine-kinase inhibitor monotherapy for patients with activating EGFR mutation-positive non-small-cell lung cancer... 
Hematology, Oncology and Palliative Medicine | TRIAL | GROWTH-FACTOR RECEPTOR | CISPLATIN PLUS GEMCITABINE | GEFITINIB | PLACEBO | EFFICACY | NSCLC | ONCOLOGY | DOUBLE-BLIND | COMBINATION | CHEMOTHERAPY | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Confidence Intervals | Prognosis | Lung Neoplasms - mortality | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Receptor, Epidermal Growth Factor - drug effects | Lung Neoplasms - pathology | Male | Bevacizumab | Dose-Response Relationship, Drug | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Squamous Cell - mortality | Neoplasm Invasiveness - pathology | Female | Quinazolines - administration & dosage | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Drug Administration Schedule | Carcinoma, Non-Small-Cell Lung - genetics | Japan | Kaplan-Meier Estimate | Treatment Outcome | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Maximum Tolerated Dose | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Neoplasm Staging | Development and progression | Care and treatment | Cross infection | Nosocomial infections | Erlotinib | Lung cancer, Non-small cell | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 516 - 524
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 1/2012, Volume 19, Issue 1, pp. 68 - 74
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 763 - 774
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 187 - 199
Summary Background We aimed to compare overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | COMPETING RISK | CLINICAL-TRIALS | THERAPY ONCOLOGY GROUP | CHEMORADIATION | INDUCTION | CARCINOMA | CHEMOTHERAPY | RADIATION-THERAPY | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Radiotherapy, Image-Guided | Chemoradiotherapy | Carcinoma, Large Cell - secondary | Neoplasm Metastasis | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Adult | Female | Cetuximab | Paclitaxel - administration & dosage | Radiotherapy Dosage | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - secondary | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Radiotherapy, Conformal | Carcinoma, Squamous Cell - secondary | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Chemotherapy | Dosage and administration | Lung cancer, Non-small cell | Antineoplastic agents | Radiotherapy | Cancer | Index Medicus
Journal Article